Direct-to-Consumer Advertising: Should There Be a Free Market in Healthcare Information?
On June 3, 2003, the European Council of health ministers rejected a proposal from the European Commission to allow drug manufacturers to advertise directly to particular groups of patients; the proposal had already been rejected by the European Parliament subsequent to a heated public debate in whi...
| Authors: | ; |
|---|---|
| Format: | Electronic Article |
| Language: | English |
| Check availability: | HBZ Gateway |
| Journals Online & Print: | Drawer...
|
| Fernleihe: | Fernleihe für die Fachinformationsdienste |
| Published: |
Cambridge Univ. Press
2006
|
| In: |
Cambridge quarterly of healthcare ethics
Year: 2006, Volume: 15, Issue: 1, Pages: 42-49 |
| Online Access: |
Volltext (lizenzpflichtig) Volltext (lizenzpflichtig) |
MARC
| LEADER | 00000naa a22000002 4500 | ||
|---|---|---|---|
| 001 | 1827979321 | ||
| 003 | DE-627 | ||
| 005 | 20221220235207.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 221220s2006 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1017/S0963180106060051 |2 doi | |
| 035 | |a (DE-627)1827979321 | ||
| 035 | |a (DE-599)KXP1827979321 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 1 |2 ssgn | ||
| 100 | 1 | |a Hasman, Andreas |e VerfasserIn |4 aut | |
| 245 | 1 | 0 | |a Direct-to-Consumer Advertising: Should There Be a Free Market in Healthcare Information? |
| 264 | 1 | |c 2006 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 520 | |a On June 3, 2003, the European Council of health ministers rejected a proposal from the European Commission to allow drug manufacturers to advertise directly to particular groups of patients; the proposal had already been rejected by the European Parliament subsequent to a heated public debate in which consumer and patient groups almost unanimously argued that it was not the role of drug companies to provide information to patients. The pilot scheme suggested by the Commission would only have applied to patients with three chronic diseases, AIDS, diabetes, and asthma, and would, it was argued, not undermine an overall ban. Drug companies would have been required to abide by a special code of conduct and clear any information given to patients—on web sites or in specialized publications—with national authorities. | ||
| 700 | 1 | |e VerfasserIn |0 (DE-588)101688954 |0 (DE-627)630198322 |0 (DE-576)325227624 |4 aut |a Holm, Søren |d 1901-1971 | |
| 773 | 0 | 8 | |i Enthalten in |t Cambridge quarterly of healthcare ethics |d Cambridge : Cambridge Univ. Press, 1992 |g 15(2006), 1, Seite 42-49 |h Online-Ressource |w (DE-627)306655039 |w (DE-600)1499985-7 |w (DE-576)081985010 |x 1469-2147 |7 nnns |
| 773 | 1 | 8 | |g volume:15 |g year:2006 |g number:1 |g pages:42-49 |
| 856 | 4 | 0 | |u https://doi.org/10.1017/S0963180106060051 |x Resolving-System |z lizenzpflichtig |3 Volltext |
| 856 | 4 | 0 | |u https://www.cambridge.org/core/journals/cambridge-quarterly-of-healthcare-ethics/article/directtoconsumer-advertising-should-there-be-a-free-market-in-healthcare-information/05542A20B71418332C486FD8828300F7 |x Verlag |z lizenzpflichtig |3 Volltext |
| 935 | |a mteo | ||
| 936 | u | w | |d 15 |j 2006 |e 1 |h 42-49 |
| 951 | |a AR | ||
| ELC | |a 1 | ||
| ITA | |a 1 |t 1 | ||
| LOK | |0 000 xxxxxcx a22 zn 4500 | ||
| LOK | |0 001 4235384236 | ||
| LOK | |0 003 DE-627 | ||
| LOK | |0 004 1827979321 | ||
| LOK | |0 005 20221220052651 | ||
| LOK | |0 008 221220||||||||||||||||ger||||||| | ||
| LOK | |0 035 |a (DE-Tue135)IxTheo#2022-12-06#B98DF6A8C61EE5D5BE3B36D404F53738EF79EAE1 | ||
| LOK | |0 040 |a DE-Tue135 |c DE-627 |d DE-Tue135 | ||
| LOK | |0 092 |o n | ||
| LOK | |0 852 |a DE-Tue135 | ||
| LOK | |0 852 1 |9 00 | ||
| LOK | |0 935 |a ixzs |a ixrk |a zota | ||
| ORI | |a SA-MARC-ixtheoa001.raw | ||